Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure-Reference-Cited by-同舟云学术

Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure

Published:1993-01 Issue:2 Volume:17 Page:220-226
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Ginès A.,Salmerón J.M.,Ginès P.,Arroyo V.,Jiménez W.,Rivera F.,Rodés J.

Publisher

Elsevier BV

Subject

Hepatology

Reference32 articles.

1. Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites;Arroyo;Am J Med,1986

2. Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease;Zipser;J Clin Endocrinol Metab,1979

3. Urinary excretion of 6-ketoprostaglandin F1 alpha, thromboxane A2 and prostaglandin E2 in cirrhosis with ascites. Relationship to functional renal failure (hepatorenal syndrome);Rimola;J Hepatol,1986

4. Renal prostaglandins in cirrhosis of the liver;Guarner;Clin Sci,1986

5. Urinary prostaglandins and renal function in chronic liver diseases;Uemura;Scand J Gastroenterol,1986

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Transjugular Intrahepatic Portosystemic Shunt on Renal and Pulmonary Function in Hepatic Decompensation with and without Hepatorenal and Hepatopulmonary Syndromes: A Review;Journal of Clinical and Translational Hepatology;2024-07-25

2. IMMUNE MECHANISMS FOR THE DEVELOPMENT OF HEPATORENAL SYNDROME IN LIVER CIRRHOSIS;Acta medica Eurasica;2020-09-25

3. Hepatic Failure;Principles of Adult Surgical Critical Care;2016

4. Hepatorenal Disorders;Chest;2015-08

5. Hepatorenales Syndrom;Weiterbildung Anästhesiologie;2015